Viz.ai partners with UCSF to commercialize AI algorithms for cardiovascular disease detection
Viz.ai, a frontrunner in artificial intelligence (AI) powered disease detection and intelligent care coordination, has inked an exclusive agreement with the University of California, San ... Read More
Adagio Medical raises $42.5m in Series E to transform cardiac ablation treatment
Adagio Medical, a California-based medical device company specializing in innovative treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), has successfully raised $42.5 million in ... Read More
Biotronik’s Acticor and Rivacor CRM devices bag FDA approval
Biotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices - Acticor and Rivacor range of devices for treating heart arrhythmia ... Read More